The Cleveland Clinic said it will not carry Biogen’s controversial Alzheimer’s drug after a panel of experts "reviewed all available scientific evidence on this medication." "Based on current data regarding its safety and efficacy, we have decided not to carry Aducanumab at this time," a Cleveland Clinic statement provided to Fox News said. DOES NEW ALZHEIMER'S DRUG WORK? CLICK HERE TO GET THE FOX NEWS APPAduhelm marked the first Alzheimer’s drug approved by the FDA in nearly 20 years, which was welcome news for many patients and organizations. The Alzheimer’s Association called the approval "the beginning of a completely new future for Alzheimer’s treatments."

Source: Fox News July 15, 2021 15:35 UTC